Eisai Inc., a leading player in the pharmaceutical arena with a keen focus on human health care (hhc), has successfully raised $1.5 billion in funding to accelerate its mission of enhancing patient outcomes. As a U.S. subsidiary of Tokyo-based Eisai Co., Ltd., the company is steadfast in its commitment to addressing unmet medical needs, particularly in the realms of oncology and neurology. With this significant financial backing, Eisai plans to bolster its research efforts and expand its portfolio of innovative therapies aimed at treating dementia-related and neurodegenerative diseases. The capital will also support advancements in its oncology division, empowering the company to further tackle cancers that currently lack effective treatments. Eisai's integrated approach, which encompasses discovery, development, and marketing, positions it uniquely in the market to respond quickly to the evolving needs of patients and their families. The funds will help enhance their already robust operational framework, which includes state-of-the-art research labs across Massachusetts and Pennsylvania and commercial teams based in New Jersey. This funding announcement marks a pivotal step for Eisai as it continues to focus on patient-centric solutions and strives to lead in the development of meaningful therapies that can transform the lives of those grappling with complex health challenges. For more information on Eisai's initiatives and ongoing projects, please visit their website at www.eisai.com/US.
Eisai Secures $1.5 Billion Funding to Advance Innovation in Healthcare
Recently funded 路 $1.5BPharmaceutical
Get the full Eisai company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
